ImportRefusal LogoImportRefusal

CAPITAL HEALTH SERVICES INDIA PV

⚠️ Moderate Risk

FEI: 3017824803 • Uppal • INDIA

FEI

FEI Number

3017824803

📍

Location

Uppal

🇮🇳

Country

INDIA
🏢

Address

Atal Incubation Centre, , Uppal, , India

Moderate Risk

FDA Import Risk Assessment

29.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
4
Unique Violations
3/3/2021
Latest Refusal
3/3/2021
Earliest Refusal

Score Breakdown

Violation Severity
62.5×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2371×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

Refusal History

DateProductViolationsDivision
3/3/2021
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
118NOT LISTED
237NO PMA
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is CAPITAL HEALTH SERVICES INDIA PV's FDA import refusal history?

CAPITAL HEALTH SERVICES INDIA PV (FEI: 3017824803) has 1 FDA import refusal record(s) in our database, spanning from 3/3/2021 to 3/3/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. CAPITAL HEALTH SERVICES INDIA PV's FEI number is 3017824803.

What types of violations has CAPITAL HEALTH SERVICES INDIA PV received?

CAPITAL HEALTH SERVICES INDIA PV has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about CAPITAL HEALTH SERVICES INDIA PV come from?

All FDA import refusal data for CAPITAL HEALTH SERVICES INDIA PV is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.